Jim Fong

Corporate Officer/Principal bei CTI BIOPHARMA CORP.

62 Jahre

Health Technology

Consumer Services

Aktive Positionen von Jim Fong

Unternehmen	Position	Beginn	Ende
CTI BIOPHARMA CORP.	Corporate Officer/Principal	01.01.2008	-
CTI BIOPHARMA CORP.	Geschäftsführer	01.01.2017	-

Unternehmen	Position	Beginn	Ende
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Vertrieb & Marketing	-	-

University of California, Los Angeles

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Chief Operating Officer	1
Corporate Officer/Principal	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.	Health Technology
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology

Private Unternehmen

Health Technology